More on GOSS
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $0.52 |
|
|||
| Open | $0.51 | ||||
| 52 Wk High | $0.00 | ||||
| 52 Wk Low | $0.00 | ||||
| Day High | $0.53 | ||||
| Day Low | $0.49 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 12,042,484 | ||||
- Gossamer Bio Inc. (GOSS) PT Lowered to $5 at H.C. Wainwright
- Gossamer Bio Inc. (GOSS) PT Lowered to $3 at Oppenheimer
- Form SCHEDULE 13G Gossamer Bio, Inc. Filed by: 683 Capital Management, LLC
- Gossamer Bio Inc. (GOSS) PT Lowered to $0.50 at Goldman Sachs
- Form SCHEDULE 13D/A Gossamer Bio, Inc. Filed by: Growth Equity Opportunities 18 VGE, LLC
- Wedbush Downgrades Gossamer Bio Inc. (GOSS) to Neutral
- Barclays Downgrades Gossamer Bio Inc. (GOSS) to Underweight
- Leerink Partners Downgrades Gossamer Bio Inc. (GOSS) to Market Perform
- BREAKING: Gossamer Bio Investors Should Contact Block & Leviton to Potentially Recover Losses After Shares Fall Over 75%
- Gossamer Bio Shareholders Are Encouraged to Contact Johnson Fistel for More Information About Potentially Recovering Their Losses
Entities mentioned with GOSS
- Earnings | View Related Stories »
- 13G | View Related Stories »
- FDA | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Definitive Agreement | View Related Stories »
- IPO | View Related Stories »
- Show More...
